Free Trial
OTCMKTS:RXMD

Progressive Care 5/15/2024 Earnings Report

Progressive Care logo
$2.11 0.00 (0.00%)
As of 09/30/2024

Progressive Care EPS Results

Actual EPS
-$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Progressive Care Revenue Results

Actual Revenue
$14.63 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Progressive Care Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Progressive Care's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules.

Conference Call Resources

Progressive Care Earnings Headlines

NextPlat Announces Results of Annual Meeting of Stockholders
Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rally right now. Over the past few weeks alone, the yellow metal surged as high as $3,500 — the highest level on record. So far this bull run playing out exactly as me and my analysts have predicted.
See More Progressive Care Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Progressive Care? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Progressive Care and other key companies, straight to your email.

About Progressive Care

Progressive Care (OTCMKTS:RXMD) (OTCMKTS: RXMD) is a diversified healthcare services company specializing in remote patient monitoring, specialty pharmacy services and medication adherence solutions. Through its integrated care delivery model, the company offers a suite of digital health technologies, home infusion therapy and personalized disease management programs designed to improve clinical outcomes and reduce hospital readmissions for patients with chronic conditions such as diabetes, heart failure, respiratory disease and hypertension.

Founded and headquartered in Tampa, Florida, Progressive Care has expanded through both organic growth and strategic acquisitions to build a national footprint across more than 25 states. Over the past two decades, the company has invested in telehealth platforms, wearable biometric sensors and proprietary software that enable real-time collection and analysis of patient vital signs. Its specialty pharmacy division provides customized compounding, specialty drug distribution and medication counseling for complex therapies, while its home infusion arm delivers parenteral nutrition and antimicrobial infusions under physician supervision.

Progressive Care’s remote patient monitoring offerings incorporate FDA-cleared devices and secure data transmission to support care coordination between patients, caregivers and healthcare providers. These solutions facilitate early intervention and personalized care plans for high-risk populations, helping payers and health systems meet quality metrics and value-based care goals. In addition, the company’s medication adherence platforms leverage smart dispensers and mobile applications to enhance compliance, refill management and outcomes tracking, particularly for elderly and homebound patients.

The company is led by Chief Executive Officer John Xanthopoulos, who brings more than 25 years of healthcare operations and technology experience. Under his tenure, Progressive Care has strengthened its partnerships with hospital systems, integrated delivery networks and managed care organizations. Guided by a mission to drive clinical innovation and patient-centric care, Progressive Care continues to pursue targeted acquisitions and product enhancements aimed at addressing the evolving needs of the U.S. healthcare market.

View Progressive Care Profile

More Earnings Resources from MarketBeat